https://www.prnewswire.co.uk/news-releases/d-e-shaw-research-licenses-first-in-class-therapeutic-for-immunological-diseases-to-lilly-832705856.html
D. E. Shaw Research Licenses First-in-Class Therapeutic for Immunological Diseases to Lilly
/PRNewswire/ -- D. E. Shaw Research (DESRES) today announced that it has entered into an exclusive global license agreement with Eli Lilly and Company...
d e shaw research